Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Exploring noncoding variants in genetic diseases: From detection to functional insights

Non-coding genetic variants in human disease

Decoding polygenic diseases: advances in noncoding variant prioritization and validation

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Understanding the Function of Regulatory DNA Interactions in the Interpretation of Non-Coding GWAS Variants

Scalable approaches for functional analyses of whole-genome sequencing non-coding variants

Regulatory variants: from detection to predicting impact

Improved Detection of Rare Genetic Variants for Diseases

Deep learning approaches for non-coding genetic variant effect prediction: current progress and future prospects

Understanding genetic variants in context

Prediction of disease-associated functional variants in noncoding regions through a comprehensive analysis by integrating datasets and features

How chromatin interactions shed light on interpreting non-coding genomic variants: opportunities and future direc-tions

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Genomic annotation of disease-associated variants reveals shared functional contexts

Genetic Study of Complex Diseases in the Post-GWAS Era

New-generation high-throughput technologies based 'omics' research strategy in human disease]

Methods for Functional Characterization of Genetic Polymorphisms of Non-Coding Regulatory Regions of the Human Genome

Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidation

Functional categorization of gene regulatory variants that cause Mendelian conditions

Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation

Computational Genomics in the Era of Precision Medicine: Applications to Variant Analysis and Gene Therapy